RELCLO Trademark

Trademark Overview

On Thursday, October 26, 2017, a trademark application was filed for RELCLO with the United States Patent and Trademark Office. The USPTO has given the RELCLO trademark a serial number of 87661023. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, June 14, 2021. This trademark is owned by Lupin Limited. The RELCLO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals for the treatment of dermatological conditions
relclo

General Information

Serial Number87661023
Word MarkRELCLO
Filing DateThursday, October 26, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, June 14, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 13, 2018

Trademark Statements

Goods and ServicesPharmaceuticals for the treatment of dermatological conditions

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, November 4, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameLupin Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressMumbai 400051
IN
Party NameLupin Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressMumbai 400051
IN

Trademark Events

Event DateEvent Description
Monday, June 14, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, June 14, 2021ABANDONMENT - NO USE STATEMENT FILED
Thursday, November 19, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 18, 2020EXTENSION 5 GRANTED
Thursday, November 5, 2020EXTENSION 5 FILED
Wednesday, November 18, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, November 5, 2020TEAS EXTENSION RECEIVED
Wednesday, April 1, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 30, 2020EXTENSION 4 GRANTED
Monday, March 30, 2020EXTENSION 4 FILED
Monday, March 30, 2020TEAS EXTENSION RECEIVED
Tuesday, October 15, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 11, 2019EXTENSION 3 GRANTED
Friday, October 11, 2019EXTENSION 3 FILED
Friday, October 11, 2019TEAS EXTENSION RECEIVED
Thursday, April 25, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 23, 2019EXTENSION 2 GRANTED
Tuesday, April 23, 2019EXTENSION 2 FILED
Tuesday, April 23, 2019TEAS EXTENSION RECEIVED
Thursday, November 8, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Saturday, November 10, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 8, 2018EXTENSION 1 GRANTED
Thursday, November 8, 2018EXTENSION 1 FILED
Thursday, November 8, 2018TEAS EXTENSION RECEIVED
Tuesday, May 8, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 13, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 13, 2018PUBLISHED FOR OPPOSITION
Wednesday, February 21, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, February 7, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, February 6, 2018ASSIGNED TO EXAMINER
Saturday, November 4, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, October 30, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

relclo conditions dermatological treatment pharmaceuticals